Dova Pharmaceuticals, Inc. (DOVA) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 113 transactions totaling $32.4M, demonstrating a bullish sentiment with $30.6M in net insider flow. The most recent transaction on Nov 12, 2019 involved a transaction of 9,635 shares valued at $0.
No significant insider buying has been recorded for DOVA in the recent period.
No significant insider selling has been recorded for DOVA in the recent period.
Based on recent SEC filings, insider sentiment for DOVA is bullish with an Insider Alignment Score of 97/100 and a net flow of $30.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Dova Pharmaceuticals, Inc. (DOVA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading DOVA stock, having executed 113 transactions in the past 90 days. The most active insider is Paul B. Manning (Executive), who has made 21 transactions totaling $416.4M.
Get notified when executives and directors at DOVA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 12, 2019 | F. Allen Lee Md Phd | Executive | Disposition | 9,635 | $N/A | $0 | |
| Nov 12, 2019 | M. Goldman Steven | Executive | Disposition | 144,280 | $N/A | $0 | |
| Nov 12, 2019 | M. Goldman Steven | Executive | Disposition | 5,000 | $N/A | $0 | |
| Nov 12, 2019 | W. Hahn Mark | Executive | Disposition | 9,024 | $N/A | $0 | |
| Nov 12, 2019 | Hoitt Jason | Executive | Disposition | 9,970 | $N/A | $0 | |
| Nov 12, 2019 | Jeffs Roger | Executive | Disposition | 66,993 | $N/A | $0 | |
| Nov 12, 2019 | Laliberte Kevin | Executive | Disposition | 4,761 | $N/A | $0 | |
| Nov 12, 2019 | B. Manning Paul | Executive | Tender | 12,979,016 | $27.50 | $356.9M | Large |
| Nov 12, 2019 | B. Manning Paul | Executive | Tender | 1,783,226 | $27.50 | $49.0M | Large |
| Nov 12, 2019 | J. Novak Alfred | Executive | Disposition | 6,901 | $N/A | $0 | |
| Nov 12, 2019 | Stalfort Sean | Executive | Tender | 635,665 | $27.50 | $17.5M | Large |
| Nov 12, 2019 | Wysenski Nancy | Executive | Disposition | 6,274 | $N/A | $0 | |
| Nov 12, 2019 | Zaccardelli David | Executive | Disposition | 76,647 | $N/A | $0 | |
| Nov 12, 2019 | Edelman Joseph | Executive | Other | 3,125,851 | $N/A | $0 | |
| Oct 1, 2019 | Zaccardelli David | Executive | Sale | 5,275 | $27.90 | $147.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 3 | $423.4M | 92.8% |
Purchase(P) | 60 | $31.5M | 6.9% |
Sale(S) | 19 | $872.0K | 0.2% |
Exercise(M) | 9 | $283.3K | 0.1% |
Disposition(D) | 10 | $0 | 0.0% |
Other(J) | 3 | $0 | 0.0% |
Award(A) | 9 | $0 | 0.0% |
Insiders at Dova Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 16 insiders making 113 transactions totaling $31.5M in purchases versus $872.0K in sales, the net buying activity of $30.6M signals strong executive confidence. Paul B. Manning (Executive) leads the buying activity with $416.4M in transactions across all time.